130 related articles for article (PubMed ID: 18758490)
1. Prion: disease or relief?
Chernoff YO
Nat Cell Biol; 2008 Sep; 10(9):1019-21. PubMed ID: 18758490
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of polyamines by the prion [PSI+].
Namy O; Galopier A; Martini C; Matsufuji S; Fabret C; Rousset JP
Nat Cell Biol; 2008 Sep; 10(9):1069-75. PubMed ID: 19160487
[TBL] [Abstract][Full Text] [Related]
3. [Yeast prions, mammalian amyloidoses, and the problem of proteomic networks].
Galkin AP; Mironova LN; Zhuravleva GA; Inge-Vechtomov SG
Genetika; 2006 Nov; 42(11):1558-70. PubMed ID: 17163073
[TBL] [Abstract][Full Text] [Related]
4. [Association between defects of karyogamy and translation termination in yeast Saccharomyces cerevisiae].
Borchsenius AS; Repnevskaia MV; Kurischko C; Inge-Vechtomov SG
Genetika; 2005 Feb; 41(2):178-86. PubMed ID: 15810607
[TBL] [Abstract][Full Text] [Related]
5. [New aspects of research upon the yeast Saccharomyces cerevisiae [PSI+] prion].
Ishikawa T
Postepy Biochem; 2007; 53(2):182-7. PubMed ID: 17969880
[TBL] [Abstract][Full Text] [Related]
6. [Phenotypic manifestation of epigenetic determinant [ISP+] in Saccharomyces serevisiae depends on combination of mutations in SUP35 and SUP45 genes].
Aksenova AIu; Volkov KV; Rovinskiĭ NS; Svitin AV; Mironova LN
Mol Biol (Mosk); 2006; 40(5):844-9. PubMed ID: 17086985
[TBL] [Abstract][Full Text] [Related]
7. Effects of the [PSI+] prion on rates of adaptation in yeast.
Joseph SB; Kirkpatrick M
J Evol Biol; 2008 May; 21(3):773-80. PubMed ID: 18312560
[TBL] [Abstract][Full Text] [Related]
8. Transformation of yeast by infectious prion particles.
King CY; Wang HL; Chang HY
Methods; 2006 May; 39(1):68-71. PubMed ID: 16759879
[TBL] [Abstract][Full Text] [Related]
9. [Prion (PSI) and its effect on termination of translation in Saccharomyces cerevisiae].
Jakubiec M; Boguta M
Postepy Biochem; 2002; 48(3):175-81. PubMed ID: 12625245
[No Abstract] [Full Text] [Related]
10. [Conservation of the MC domains in eukaryotic termination factor eRF3].
Zhuravleva GA; Zemlianko OM; Le Goff C; Petrova AV; Philippe M; Inge-Vechtomov SG
Genetika; 2007 Jan; 43(1):38-44. PubMed ID: 17333937
[TBL] [Abstract][Full Text] [Related]
11. [Chimeric yeast prions with unstable inheritance].
Borkhsenius AS; Sasnauskas K; Gedvilaĭte A; Inge-Vechtomov SG
Genetika; 2002 Mar; 38(3):300-5. PubMed ID: 11963556
[TBL] [Abstract][Full Text] [Related]
12. [Suppression of nonsense and frameshift mutations obtained by different methods for inactivating the translation termination factor eRF3 in yeast Saccharomyces cerevisiae].
Zadorskiĭ SP; Borkhsenius AS; Sopova IuV; Startsev VA; Inge-Vechtomov SG
Genetika; 2003 Apr; 39(4):489-94. PubMed ID: 12760248
[TBL] [Abstract][Full Text] [Related]
13. Translation termination and its regulation in eukaryotes: recent insights provided by studies in yeast.
Mugnier P; Tuite MF
Biochemistry (Mosc); 1999 Dec; 64(12):1360-6. PubMed ID: 10648959
[TBL] [Abstract][Full Text] [Related]
14. [Increased tRNA concentration in yeast containing mutant termination translation factors eRF1 and eRF3].
Zhuravleva GA; Moskalenko SE; Shabel'skaia SV; Philippe M; Inge-Vechtomov SG
Mol Biol (Mosk); 2006; 40(4):724-30. PubMed ID: 16913231
[TBL] [Abstract][Full Text] [Related]
15. Cell biology: the strain of being a prion.
Tuite MF
Nature; 2004 Mar; 428(6980):265-7. PubMed ID: 15029177
[No Abstract] [Full Text] [Related]
16. The role of N-terminal domain of translational release factor eRF3 for the control of functionality and stability in S. cerevisiae.
Kodama H; Ito K; Nakamura Y
Genes Cells; 2007 May; 12(5):639-50. PubMed ID: 17535254
[TBL] [Abstract][Full Text] [Related]
17. Increased -1 ribosomal frameshifting efficiency by yeast prion-like phenotype [PSI+].
Park HJ; Park SJ; Oh DB; Lee S; Kim YG
FEBS Lett; 2009 Feb; 583(4):665-9. PubMed ID: 19166852
[TBL] [Abstract][Full Text] [Related]
18. N-terminal extension of Saccharomyces cerevisiae translation termination factor eRF3 influences the suppression efficiency of sup35 mutations.
Volkov K; Osipov K; Valouev I; Inge-Vechtomov S; Mironova L
FEMS Yeast Res; 2007 May; 7(3):357-65. PubMed ID: 17302942
[TBL] [Abstract][Full Text] [Related]
19. A yeast-based assay to isolate drugs active against mammalian prions.
Bach S; Tribouillard D; Talarek N; Desban N; Gug F; Galons H; Blondel M
Methods; 2006 May; 39(1):72-7. PubMed ID: 16750390
[TBL] [Abstract][Full Text] [Related]
20. Blessings in disguise: biological benefits of prion-like mechanisms.
Newby GA; Lindquist S
Trends Cell Biol; 2013 Jun; 23(6):251-9. PubMed ID: 23485338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
